GBP6’s reduction in oral squamous cell carcinoma and tongue squamous cell carcinoma hints at diagnostic potential, measurable in saliva, tissue biopsies, or circulating DNA via qPCR, RNA sequencing, or liquid biopsies, pending larger cohort confirmation [50]. This evidence concerns the gene GBP6 and oral cavity squamous cell carcinoma.